Skip to main content
NCBI home page
Molecules logoLink to Molecules
. 2019 Dec 13;24(24):4575. doi: 10.3390/molecules24244575

A New Valuable Synthesis of Polyfunctionalized Furans Starting from β-Nitroenones and Active Methylene Compounds

Elena Chiurchiù 1, Serena Gabrielli 1, Roberto Ballini 1, Alessandro Palmieri 1,*
Editor: Paola Vitale1
PMCID: PMC6943492  PMID: 31847286

Abstract

Highly functionalized furans are the key scaffolds of many pharmaceuticals and bioactive natural products. Herein, we disclose a new fruitful synthesis of polyfunctionalized furans starting from β-nitroenones and α-functionalized ketones. The protocol involves two steps promoted by solid supported species, and it provides the title targets from satisfactory to very good overall yields and in an excellent diastereomeric ratios.

Keywords: furans, heterocycles, solid supported species, β-nitroenones, cyclization

1. Introduction

Furan ring is a useful building block of many biologically active targets, it is the core of many natural compounds and important polymers, and several furan-containing scaffolds serve as privileged structures in medicinal chemistry [1,2,3,4,5,6]. In this context, its significant importance has spurred the scientific community to investigate ever more efficient methodologies for preparing polyfunctionalized furan-based scaffolds, which, in turn, are suitable for further synthetic manipulations. In particular, complex furan derivatives can be achieved by the derivatization of a preexisting furan structure [7,8,9], or by the ex novo ring construction, planning the introduction of specific functionalities in the opportune positions [10,11,12,13].

Herein, following our studies on the preparation of heteroaromatic systems starting from aliphatic nitro compounds [14,15,16,17], we found β-nitroenones 1 and α-functionalized ketones 2 to be precious and practical building blocks of 3-alkylidene furans 3. In particular, this study complements our previous research concerning the reaction of α-functionalized ketones 2 with β-nitroacrylates 4 [18] to produce, by a different reaction mechanism, the tetrasubstituted furans 5 (Figure 1).

Figure 1.

Figure 1

Open in a new tab

Usage of α-functionalized ketones 2 in combination with β-nitroenones 1 or β-nitroacrylates 4, for synthesizing tetrasubstituted furans.

The new protocol involves two steps (Scheme 1): (i) a base promoted addition of 2 to 1 for giving the adduct I, which eliminates a molecule of nitrous acid [19], to provide the intermediate 6 and (ii) the acidic catalyzed cyclization of 6 (passing through the adducts II and III) into the title targets 3.

Scheme 1.

Scheme 1

Open in a new tab

Probable reaction mechanism.

2. Results and Discussion

In our attempt to maximize the process efficacy, we separately studied the two steps. At the beginning, we focused our attention on the domino addition-elimination process (Step I), using, as sample substrates, the β-nitroenone 1a and diketone 2a in stoichiometric ratio (Scheme 2).

Scheme 2.

Scheme 2

Open in a new tab

Domino addition–elimination process (I Step).

Initially, we tested different supported bases, conducting the reactions in acetonitrile. The best yield of 6a was obtained after 2 h (complete conversion), using 1 eq. of PS-carbonate at room temperature (Figure 2).

Figure 2.

Figure 2

Open in a new tab

Screening of different supported bases conducting the reaction in MeCN, at room temperature, after two hours (yield of the pure isolated product).

Then, once we identified the best base for promoting the one-pot addition-elimination process, we moved our attention to the selection of the reaction media. In this sense, a variety of solvents were screened, and, as depicted in the Figure 3, acetonitrile was the most effective; only ethyl acetate provided 6a in acceptable yield.

Figure 3.

Figure 3

Open in a new tab

Screening of different solvents conducting the reaction for 2 h, at room temperature and in the presence of 1 eq. of PS-carbonate (yield of the pure isolated product).

After the optimization of the I step (1 eq. of PS-carbonate, MeCN, room temperature, 2 h), we performed an analogous study to optimize the reaction conditions for converting 6a into the tetrasubstituted furan 3a (II Step, Scheme 3). In this regard, and based on our experience about the use of Amberlyst 15 for promoting cyclization reactions [11,15,20], we explored this heterogeneous acidic species in different solvents and reaction temperatures (Table 1).

Scheme 3.

Scheme 3

Open in a new tab

Acidic catalyzed cyclization of 6a into 3a (II Step).

Table 1.

Optimization studies of the II Step: conversion of 6a into 3a.

Entry Amberlyst 15 (g/mmol) Solvent Temperature (°C) 1 Time (h) Yield (%) of 3a 2 E:Z
a 1 MeCN 80 2 53 96:4
b 1 EtOAc 80 2 76 96:4
c 1 Toluene 80 2 68 82:18
d 1 2-MeTHF 80 2 58 90:10
e 1 EtOAc 100 1 74 90:10
f 1 EtOAc 60 4 45 96:4
g 1.2 EtOAc 80 2 82 96:4
h 0.8 EtOAc 80 2 89 96:4
i 0.6 EtOAc 80 2 91 96:4
j 0.4 EtOAc 80 2 85 96:4
Open in a new tab

1 Reaction performed under microwave irradiations in a sealed vessel. 2 Yield of the pure isolated product.

As reported in Table 1, the use of 0.6 g/mmol of Amberlyst 15 in EtOAc, at 80 °C, produces, after two hours, 6a in excellent yield and diastereomeric ratio (Entry i, 91%, E:Z = 96:4). After increasing the temperature to 100 °C, the reaction finished in one hour, however the yield and the diastereomeric ratio decreased to 74% and 90:10, respectively. On the other hand, at a lower temperature (60 °C), we observed a longer reaction time (four hours) and a dramatic cutoff of the yield to 45%, albeit the diastereomeric ratio remained unchanged, at 96:4.

Additional heterogeneous acidic species, such as Montmorillonite K10, acidic alumina, BF3/SiO2, AlCl3/SiO2, and Dowex® 50Wx8-200 were also tested. Acidic alumina was completely ineffective (recovered only 6a); BF3 and AlCl3 on SiO2 provided a complex and inseparable mixture of byproducts, while Montmorillonite K10 and Dowex® provided 3a in 13% and 24% of yield, respectively.

Successively, in order to minimize the waste production and the energy consumption, we coupled the two steps, avoiding the purification of the intermediate 6a. In this aim, after the accomplishment of the I Step, PS-carbonate was removed by filtration, the resin was washed with fresh EtOAc, and then the solvent was evaporated under reduced pressure to give the crude adduct 6a, which was directly submitted to the II Step, providing 3a in 74% overall yield (Scheme 4). It is important to note that this result is absolutely comparable with that obtained over the two distinct steps (I Step 85%, II Step 91%, which correspond to a total yield of 77%).

Scheme 4.

Scheme 4

Open in a new tab

Overall synthesis of 3a.

Finally, with the scope to assess the generality of our protocol, we submitted a variety of β-nitroenones 1 and functionalized ketones 2 to the optimized reaction conditions (Scheme 5). Thanks to the mild conditions, it was possible to install a variety of functionalities on the furan ring (ketone, ester, nitrile, and sulfone), obtaining the products 3a–n from satisfactory to very good overall yields (37–88%), and in excellent diastereomeric ratios (E:Z > 93:7), with the exception of compound 3f (E:Z = 65:35). Furans 3i and 3l–n were isolated as single E diastereoisomer.

Scheme 5.

Scheme 5

Open in a new tab

Substrate scope demonstration.

3. Conclusions

In conclusion, by exploiting the high reactivity of β-nitroenones, we developed a new general and efficient two-step protocol for synthesizing poly-functionalized furans in good overall yields and excellent diastereoselectivity. In particular, thanks to the mild reaction conditions, a plethora of functional groups can be tolerated, thus giving the possibility to install several functionalities on the furan ring, such as ketone, ester, nitrile, and sulfone. Moreover, since the use of solid supported species in both steps, it was possible to avoid the use of the typical wasteful aqueous work-up, reducing the operation to a simple filtration, with evident advantages from the sustainability viewpoint.

4. Materials and Methods

4.1. General Section

OXFORD NMR S400, Varian Mercury Plus 400, Oxford, United Kingdom, equipped with workstation Sun Blade 150, software VNMRJ 1.1d, and operating system Solaris 9. 1H NMR analyses were recorded at 400 MHz and 13C NMR analyses were recorded at 100 MHz. Ir spectra were recorded with a Spectrum Two FT-IR spectrometer, Waltham, MA, United States equipped with ZnSe window, Dynascan Interferometer, detector type LiTaO3, and Spectrum 10 software. Microanalyses were performed with a CHNS-O analyzer Model EA 1108 from Fisons Instruments. GS-MS analyses were obtained on an Agilent GC(6850N)/MS(5973N), Stevens Creek Blvd, Santa Clara, CA, United States, EI technique (70 eV), GC/MSD software, and an HP-5MS column, 30 m, Id 0.25 µm, film thichness 0.25 µm. Microwave irradiations were performed by means of a Biotage® Initiator+ from Biotage, Uppsala, Sweden. Compound 3j is known, and its spectroscopic data are in agreement with those reported in the literature [21].

4.2. Chemistry Section

General procedure for the preparation of compounds 3a–n: PS-carbonate (0.286 g, 1 mmol) was added to a stirred solution of the appropriate β-nitroenone 1 (1 mmol) and ketone 2 (1 mmol) in acetonitrile (2 mL, 0.5 M), and the resulting solution was stirred at room temperature for the appropriate time (see Scheme 4). Then the resin was filtered off by washing with fresh ethyl acetate (10 mL), and the crude intermediate 6, obtained after removal of the solvent under reduced pressure, was solubilized in ethyl acetate (12 mL) and treated with Amberlyst 15 (0.6 g) and irradiated Biotage® Initiator+, at 80 °C, for 2 h. Finally, the Amberlyst 15 was removed by filtration (washing with fresh ethyl acetate, 10 mL), the solvent evaporated under vacuum, and the crude product 3 obtained from it was purified by flash chromatography column (95:5 hexane/Et2O).

Compound6a. Clear oil. IR (cm−1, neat): 733, 1597, 1646. 1H-NMR (CDCl3, 400 MHz) δ: 1.07 (t, 3H, J = 7.5 Hz), 2.01 (s, 6H), 2.24 (qui, 2H, J = 7.5 Hz), 6.65 (t, 1H, J = 7.5 Hz), 7.44–7.50 (m, 2H), 7.54–7.59 (m, 1H), 7.69–7.73 (m, 2H), 15.77 (s, 1H). 13C-NMR (100 MHz) δ: 12.9, 23.8, 23.9, 107.9, 128.6, 129.6, 132.2, 136.5, 138.5, 153.2, 191.2, 191.3, 197.0. GC-MS (70 eV): m/z: 258 (13), 229 (100), 187 (14), 151 (26), 105 (56), 77 (49), 43 (77). Anal. Calcd. for C16H18O3 (253.32): C, 74.40; H, 7.02. Found: C, 74.44; H, 6.98.

Compound3a. Pale yellow oil. IR (cm−1, neat): 693, 764, 950, 1667, 2919. 1H-NMR (CDCl3, 400 MHz) δ: 1.87 (dd, 3H, J = 1.8, 6.6 Hz, CH3CH), 2.44 (s, 3H, CH3CO), 2.58 (s, 3H, CH3), 5.81 (dq, 1H, J = 6.6, 15.9 Hz, CHCH3), 6.46 (dq, 1H, J = 1.8, 15.9 Hz, CH=CH), 7.25–7.29 (m, 1H, p-Ph), 7.35–7.40 (m, 2H, m-Ph), 7.66–7.69 (m, 2H, o-Ph). 13C-NMR (100 MHz) δ: 14.7, 19.0, 31.4, 119.3, 121.8, 125.4, 126.4, 127.7, 128.6, 131.1, 132.4, 147.4, 156.8, 196.5. GC-MS (70 eV): m/z: 240 (100), 225 (50), 197 (25), 183 (12), 155 (14), 153 (13), 152 (12), 105 (19), 77 (26), 43 (47). Anal. Calcd. for C16H16O2 (240.3): C, 79.97; H, 6.71. Found: C, 80.02; H, 6.75.

Compound3b. Yellow waxy solid. IR (cm−1, neat): 689, 764, 927, 1671, 2939, 2974. 1H-NMR (CDCl3, 400 MHz) δ: 1.14 (t, 3H, J = 7.31 Hz, CH3CH2CO), 1.29, (t, 3H, J = 7.54 Hz CH3CH2), 1.87 (dd, 3H, J = 1.8, 6.6 Hz, CH3CH), 2.72 (q, 2H, J = 7.3 Hz, CH2CO), 2.91 (q, 2H, J = 7.5 Hz, CH2), 5.77 (dq, 1H, J = 6.6, 15.9 Hz, CHCH3), 6.46 (dq, 1H, J = 1.8, 15.9 Hz, CH=CH), 7.24–7.29 (m, 1H, p-Ph), 7.35–7.41 (m, 2H, m-Ph), 7.65–7.69 (m, 2H, o-Ph). 13C-NMR (100 MHz) δ: 8.5, 12.7, 19.0, 21.8, 36.6, 119.0, 122.0, 125.4, 126.4, 127.6, 128.6, 131.2, 132.1, 147.3, 160.6, 200.4. GC-MS (70 eV): m/z: 268 ([M+], 76), 239 (100), 211 (18), 155 (15), 105 (3), 77 (26), 57 (25), 29 (10). Anal. Calcd. for C18H20O2 (268.36): C, 80.56; H, 7.51. Found: C, 7.55; H, 7.54.

Compound3c. Yellow oil. IR (cm−1, neat): 732, 831, 1026, 1176, 1246, 1505, 1667, 2839, 2935. 1H-NMR (CDCl3, 400 MHz) δ: 1.86 (dd, 3H, J = 1.8, 6.6 Hz, CH3CH), 2.40 (s, 3H, CH3CO), 2.54 (s, 3H, CH3), 3.83 (s, 3H, CH3O), 5.78 (dq, 1H, J = 6.6, 15.9 Hz, CHCH3), 6.42 (dq, 1H, J = 1.8, 15.9 Hz, CH=CH), 6.87–6.93 (m, 2H, m-Ar), 7.57–7.61 (m, 2H, o-Ar). 13C-NMR (100 MHz) δ: 14.7, 19.0, 31.4, 55.5, 114.1, 117.9, 122.0, 123.8, 126.9, 127.9, 132.0, 147.6, 156.3, 159.2, 196.6. GC-MS (70 eV): m/z: 270 ([M+], 100), 255 (25), 227 (24), 213 (16), 185 (13), 135 (14), 43 (34). Anal. Calcd. for C17H18O3 (270.33): C, 75.53; H, 6.71. Found: C, 75.48; H, 6.67.

Compound3d. Orange oil. IR (cm−1, neat): 835, 950, 1247, 1505, 1667, 2931, 2966. 1H-NMR (CDCl3, 400 Hz) δ: 1.91 (dd, 3H, J = 1.7, 6.6 Hz, CH3CH), 2.40 (s, 3H, CH3CO), 2.55 (s, 3H, CH3), 5.94 (dq, 1H, J = 6.6, 15.9 Hz, CHCH3), 6.38 (dq, 1H, J = 1.8, 15.9 Hz, CH=CH), 7.03 (dd, 1H, J = 3.6, 5.1 Hz, CHCH=CH), 7.23 (dd, 1H, J = 1.2, 5.1 Hz, CCHCH), 7.32 (dd, 1H, J = 1.2, 3.6 Hz, CHS). 13C-NMR (100 MHz) δ: 14.8, 19.0, 31.4, 118.8, 121.3, 124.1, 124.4, 124.8, 127.3, 132.7, 133.7, 143.7, 156.9, 196.1. GC-MS (70 eV): m/z: 248 ([M+2+], 5) 246 ([M+], 100), 231 (31), 203 (20), 189 (13), 161 (17), 111 (21), 43 (39). Anal. Calcd. for C14H14O2S (246.32): C, 68.27; H, 5.73; S, 13.02. Found: C, 68.33; H, 5.69; S, 12.98.

Compound3e. Yellow oil. IR (cm−1, neat): 693, 764, 906, 1330, 1445, 1596, 1651, 2851, 2914, 3061. 1H-NMR (CDCl3, 400 MHz) δ: 1.6 (dd, 3H, J = 1.7, 6.6 Hz, CH3CH), 2.30 (s, 3H, CH3), 5.61 (dq, 1H, J = 6.6, 15.9 Hz, CHCH3), 6.30 (dq, 1H, J = 1.7, 15.9 Hz, CH=CH), 7.28–7.33 (m, 1H, p-Ph), 7.39–7.47 (m, 4H, m-Ph, m-PhCO), 7.53–7.58 (m, 1H, p-PhCO), 7.65–7.69 (m, 2H, o-Ph), 7.84–7.88 (m, 2H, o-PhCO). 13C-NMR (100 MHz) δ: 13.7, 19.0, 119.9, 120.4, 122.7, 126.6, 127.8, 128.7, 128.8, 129.9, 131.1, 131.4, 133.2, 138.7, 147.8, 154.6, 139.6. GC-MS (70 eV): m/z: 302 ([M+], 100), 288 (18), 105 (61), 77 (45). Anal. Calcd. for C21H18O2 (302.37): C, 83.42; H, 6.00. Found: C, 83.47; H, 6.04.

Compound3f (Diastereomeric ratio E:Z = 65:35). Pale yellow oil. IR (cm−1, neat): 633, 835, 950, 1029, 1176, 1247, 1505, 1667, 2930, 2966. 1H-NMR (CDCl3, 400 MHz) δ: 1.25 (s, 3.15H, (Z) tBu), 1.28 (s, 5.85H, (E) tBu), 1.53 (dd, 1.05H, J = 1.8, 6.6 Hz, (Z) CH3CH), 1.83 (dd, 1.95H, J = 1.8, 6.6 Hz, (E) CH3CH), 2.30 (s, 1.05H, (Z) CH3CO), 2.31 (s, 1.95H, (E) CH3CO), 2.43 (s, 1.95H, (E) CH3), 2.47 (s, 1.05H, (Z) CH3), 5.56 (dq, 0.65H, J = 6.6, 15.9 Hz, (E) CHCH3), 5.81 (dq, 0.35H, J = 6.6, 11 Hz, (Z) CHCH3), 6.29–6.34 (m, 1H, (E,Z) CH=CH). 13C-NMR (100 MHz) δ:14.4, 14.7, 14.8, 18.7, 29.4, 30.0, 30.1, 31.5, 33.9, 34.1, 113.2, 116.2, 123.0, 123.6, 123.7, 124.0, 130.3, 131.5, 154.5, 155.6, 155.7, 156.1, 196.6, 197.1. GC-MS (70 eV): m/z: 220 ([M+], 35), 205 (100), 163 (10), 145 (12), 43 (37). Anal. Calcd. for C14H20O2 (220.31): C, 76.33; H, 9.15. Found: C, 76.37; H, 9.18.

Compound3g. Yellow oil. IR (cm−1, neat): 693, 764, 1097, 1211, 1707, 2938, 2978. 1H-NMR (CDCl3, 400 MHz) δ: 1.29 (t, 3H, J = 7.5 Hz, CH3CH2), 1.37 (t, 3H, J = 7.1 Hz, CH3CH2O), 1.83 (dd, 3H, J = 1.8, 6.6 Hz, CH3CH), 3.00 (q, 2H, J = 7.5 Hz, CH2), 4.31 (q, 2H, J = 7.1 Hz, CH2O), 5.94 (dq, 1H, J = 6.6, 16.0 Hz, CHCH3), 6.50 (dq, 1H, J = 1.8, 16.0 Hz, CH=CH), 7.24–7.29 (m, 1H, p-Ph), 7.34–7.39 (m, 2H, m-Ph), 7.68–7.71 (m, 2H, o-Ph). 13C-NMR (100 MHz) δ: 12.6, 14.5, 19.1, 21.9, 60.3, 113.9, 119.9, 121.4, 125.4, 126.7, 127.7, 128.6, 130.9, 131.4, 163.1, 164.7. GC-MS (70 eV): m/z: 284 ([M+], 100), 269 (12), 255 (50), 239 (16), 237 (35), 223 (11), 211 (11), 209 (10), 195 (11), 182 (13), 181 (12), 165 (10), 153 (11), 152 (12), 105 (34), 77 (32). Anal. Calcd. for C18H20O3 (284.35): C, 76.03; H, 7.09. Found: C, 75.98; H, 7.04.

Compound3h. Yellow oil. IR (cm−1, neat): 689, 764, 1065, 1223, 1485, 1714, 2910, 2934, 2978. 1H-NMR (CDCl3, 400 MHz) δ: 1.32 (t, 3H, J = 7.1 Hz, CH3), 1.88 (dd, 3H, J = 7.1 Hz, CH3CH), 4.34 (q, 2H, J = 7.1 Hz, CH2), 6.00 (dq, 1H, J = 6.6, 16 Hz, CHCH3), 6.51 (dq, 1H, J = 1.8, 16 Hz, CH=CH), 7.30–7.46 (m, 6H, m,p-Ph), 7.74–7.82 (m, 4H, o-Ph). 13C-NMR (100 MHz) δ: 14.3, 19.2, 61.2, 115.8, 120.9, 125.7, 126.9, 127.7, 128.1, 128.3, 128.5, 128.8, 129.1, 130.2, 130.9, 148.8, 153.9, 165.5. GC-MS (70 eV): m/z: 332 ([M+], 100), 285 (33), 269 (25), 215 (13), 105 (57), 77 (29). Anal. Calcd. for C22H20O3 (332.40): C, 79.50; H, 6.07. Found: C, 79.47; H, 6.03.

Compound3i. Yellow waxy solid. IR (cm−1, neat) 693, 760, 966, 1093, 1211, 1441, 1707, 2851, 2907, 2950, 3025. 1H-NMR (CDCl3, 400 MHz) δ: 2.61 (s, 3H, CH3), 3.53 (dd, 2H, J = 1.4, 7.1 Hz, CH2), 3.81 (s, 3H, CH3O), 6.07 (dt, 1H, J = 7.1, 16 Hz, CHBn), 6.59 (dt, 1H, J = 1.6, 16 Hz, CH=CH), 7.20–7.35 (m, 8H, m,p-Ph, m,o,p-PhCH2), 7.64–7.68 (m, 2H, o-Ph). 13C-NMR (100 MHz) δ: 14.6, 40.0, 51.4, 114.6, 119.5, 121.6, 126.32, 126.8, 127.8, 128.6, 128.7, 128.7, 131.0, 134.2, 140.1, 148.0, 158.8, 156.2. GC-MS (70 eV): m/z: 332 ([M+], 100), 300 (100), 284 (40), 257 (22), 241 (19), 230 (29), 223 (44), 209 (19), 182 (9), 165 (10), 152 (15), 115 (15), 105 (29), 91 (29), 77 (33), 43 (14). Anal. Calcd. for C22H20O3 (332.40): C, 79.50; H, 6.07. Found: C, 79.54; H, 6.10.

Compound3j. Clear oil. IR (cm−1, neat) 665, 693, 768, 950, 1069, 1132, 1390, 1667, 2922, 2954. 1H-NMR (CDCl3, 400 MHz) δ: 2.44 (s, 3H, CH3CO), 2.57 (s, 3H, CH3), 5.41 (dd, 1H, J = 1.7, 24.4 Hz, CH), 5.44 (dd, 1H, J = 1.7, 17.7 Hz, CH), 6.84 (dd, 1H, J = 11.2, 17.7 Hz, CH=CH2), 7.27–7.32 (m, 1H, p-Ph), 7.35–7.41 (m, 2H, m-Ph), 7.66–7.70 (m, 2H, o-Ph). 13C-NMR (100 MHz) δ: 14.7, 31.5, 119.5, 120.7, 124.2, 126.7, 128.0, 128.7, 128.8, 130.7, 148.0, 156.8, 196.3. GC-MS (70 eV): m/z: 226 ([M+], 100), 225 (77), 211 (22), 183 (40), 165 (15), 155 (23), 141 (22), 115 (19), 105 (18), 77 (25), 43 (41). Anal. Calcd. for C15H14O2 (226.27): C, 79.62; H, 6.24. Found: C, 79.67; H, 6.20.

Compound3k. Yellow waxy solid. IR (cm−1, neat): 693, 768, 926, 1671, 2938, 2978. 1H-NMR (CDCl3, 400 MHz) δ: 1.14 (t, 3H, J = 7.3 Hz, CH3CH2CO), 1.30 (t, 3H, J = 7.5 Hz, CH3CH2), 2.75 (q, 2H, J = 7.3 Hz, CH2CO), 2.91 (q, 2H, J = 7.5, CH2), 5.35 (dd, 1H, J = 1.7, 17.7 Hz, CH), 5.41 (dd, 1H, J = 1.7, 11.2 Hz, CH), 6.83 (dd, 1H, J = 11.2, 17.7 Hz, CH=CH2), 7.27–7.32 (m, 1H, p-Ph), 7.36–7.41 (m, 2H, m-Ph), 7.65–7.70 (m, 2H, o-Ph). 13C-NMR (100 MHz) δ: 8.5, 12.8, 21.7, 36.7, 119.2, 120.3, 123.1, 126.7, 127.9, 128.7, 128.7, 130.9, 147.9, 160.5, 200.3. GC-MS (70 eV): m/z: 254 ([M+], 100), 253 (40), 235 (20), 225 (68), 197 (23), 141 (27), 115 (13), 105 (50), 77 (29), 57 (23), 29 (10). Anal. Calcd. for C17H18O2 (254.33): C, 80.28; H, 7.13. Found: C, 80.24; H, 7.10.

Compound3l. Pale yellow waxy. IR (cm−1, neat): 685, 764, 962, 1489, 2225, 2859, 2926, 2954. 1H-NMR (CDCl3, 400 MHz) δ: 0.95 (t, 3H, J = 7.2 Hz, CH3), 1.37–1.56 (m, 4H, CH3CH2CH2), 2.25–2.32 (m, 2H, CH2CH), 6.43 (dt, 1H, J = 1.5, 16.1 Hz, CH=CH), 6.63 (dt, 1H, J = 6.9, 16.1 Hz, CHBu), 7.37–7.53 (m, 6H, m,p-Ph, m,p-Ph), 7.66–7.70 (m, 2H, o-Ph), 8.05–8.09 (m, 2H, o-Ph). 13C-NMR (100 MHz) δ: 14.2, 22.5, 31.4, 33.6, 93.0, 115.9, 117.9, 121.0, 125.8, 127.0, 128.3, 128.8, 129.0, 129.3, 129.8, 130.3, 136.8, 149.0, 159.0. GC-MS (70 eV): m/z: 327 ([M+], 100), 284 (34), 250 (29), 206 (10), 105 (48), 77 (33). Anal. Calcd. for C23H21NO (327.43): C, 84.37; H, 6.46; N, 4.28. Found: C, 84.41; H, 6.42; N, 4.31.

Compound3m. Yellow waxy solid. IR (cm−1, neat): 671, 691, 766, 1491, 2231, 2924, 3023, 3058. 1H-NMR (CDCl3, 400 MHz) δ: 3.63 (dd, 2H, J = 1.2, 6.7 Hz, CH2), 6.46 (dt, 1H, J = 1.6, 16.1 Hz, CH=CH), 6.82 (dt, 1H, J = 6.7, 16.1 Hz, CHBn), 7.17–7.54 (m, 11H, m,o,p-PhCH2, m,p-Ph, m,p-Ph), 7.62 (m, 2H, o-Ph), 8.04–8.09 (m, 2H, o-Ph). 13C-NMR (100 MHz) δ: 39.9, 92.8, 115.8, 119.5, 120.6, 125.8, 126.6, 127.0, 128.2, 128.8, 128.9 (2C), 129.0, 129.3, 129.6, 130.4, 134.5, 139.5, 149.5, 159.2. GC-MS (70 eV): m/z: 361 ([M+], 100), 360 (89), 270 (14), 269 (13), 105 (29), 77 (26). Anal. Calcd. for C26H19NO (361.44): C, 86.40; H, 5.30; N, 3.88. Found: C, 86.45; H, 5.33; N, 3.84.

Compound3n. Yellow oil. IR (cm−1, neat): 558, 605, 685, 1160, 1318, 1445, 2859, 2926, 2958. 1H-NMR (CDCl3, 400 MHz) δ: 0.9 (t, 3H, J = 7.2 Hz, CH3), 1.23–1.37 (m, 4H, CH3CH2CH2), 2.06–2.12 (m, 2H, CH2CH), 2.73 (s, 3H, CH3), 5.78 (dt, 1H, J = 7.7, 16.1 Hz, CHBu), 6.29 (dt, 1H, J = 1.6, 16.1, CH=CH), 7.24–7.59 (m, 6H, m,p-Ph, m,p-PhS), 7.62–7.66 (m, 2H, o-Ph), 7.86–7.94 (m, 2H, o-PhS). 13C-NMR (100 MHz) δ: 14.0, 14.2, 22.5, 31.1, 33.2, 118.1, 122.8, 126.7, 127.3, 128.0, 128.2, 128.6, 129.1, 130.3, 133.2, 138.7, 142.9, 148.2, 156.9. GC-MS (70 eV): m/z: ([M+2+], 7), 380 ([M+], 100), 232 (31), 311 (69), 196 (36), 182 (53), 153 (25), 125 (15), 105 (73), 77 (75), 43 (29). Anal. Calcd. for C23H24O3S (380.50): C, 72.60; H, 6.36; S, 8.43. Found: C, 72.65; H, 6.39; S, 8.39.

Acknowledgments

The authors thank University of Camerino for the financial support.

Abbreviations

PS-carbonate carbonate on polymer support (Sigma-Aldrich code: 21850: loading: 3.5 mmol/g)
PS-DMAP 4-(dimethylamino)pyridine, polymer-bound (Sigma-Aldrich code: 39410, loading: 3 mmol/g)
PS-BEMP 2-tert-butylimino-2-diethylamino-1,3-dimethylperhydro-1,3,2-diazaphosphorine, polymer-bound (Sigma-Aldrich code: 20026, loading: 2.2 mmol/g)
PS-TBD 1,5,7-Triazabicyclo[4.4.0]dec-5-ene bound to polystyrene (Sigma-Aldrich code: 01961, loading: 3.0 mmol/g)
PS-F fluoride on polymer support (Sigma-Aldrich code: 47060, loading: 3.0 mmol/g)
KF/alumina potassium fluoride on aluminum oxide (Sigma-Aldrich code: 60244, loading: 5.5 mmol/g)
Open in a new tab

Author Contributions

Conceptualization, E.C. and S.G.; Methodology, S.G.; Investigation, E.C.; Validation, E.C. and S.G.; Data Curation, E.C.; Writing-Original Draft Preparation, A.P.; Writing-Review and Editing, A.P.; Supervision, R.B.; Project administration, A.P.; Funding Acquisition, A.P.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflicts of interest.

Footnotes

Sample Availability: Samples of the compounds 3a–n are available from the authors.

References

  • 1.Lipshutz B.H. Five-membered heteroaromatic rings as intermediates in organic synthesis. Chem. Rev. 1986;865:795–819. doi: 10.1021/cr00075a005. [DOI] [Google Scholar]
  • 2.Merritt A.T., Ley S.V. Clerodane diterpenoids. Nat. Prod. Rep. 1992;9:243–287. doi: 10.1039/np9920900243. [DOI] [PubMed] [Google Scholar]
  • 3.Mortensen D.S., Rodriguez A.L., Carlson K.E., Sun J., Katzenellenbogen B.S., Katzenellenbogen J.A. Synthesis and biological evaluation of a novel series of furans:  ligands selective for estrogen receptor α. J. Med. Chem. 2001;44:3838–3848. doi: 10.1021/jm010211u. [DOI] [PubMed] [Google Scholar]
  • 4.Gandini A., Lacerda T.L., Carvalho A.J.F., Trovatti E. Progress of polymers from renewable resources: Furans, vegetable oils, and polysaccharides. Chem. Rev. 2016;116:1637–1669. doi: 10.1021/acs.chemrev.5b00264. [DOI] [PubMed] [Google Scholar]
  • 5.Dhiman S., Ramasastry S.S.V. Taming furfuryl cations for the synthesis of privileged structures and novel scaffolds. Org. Biomol. Chem. 2013;11:4299–4303. doi: 10.1039/c3ob40814k. [DOI] [PubMed] [Google Scholar]
  • 6.Yet L. Privileged Structures in Drug Discovery: Medicinal Chemistry and Synthesis. 1st ed. John Wiley & Sons Inc.; Hoboken, NJ, USA: 2018. [DOI] [Google Scholar]
  • 7.Hou X.L., Cheung H.Y., Hon T.Y., Kwan P.L., Lo T.H., Tong S.Y., Wong H.N.C. Regioselective syntheses of substituted furans. Tetrahedron. 1998;51:1955–2020. doi: 10.1016/S0040-4020(97)10303-9. [DOI] [Google Scholar]
  • 8.Melzig L., Rauhut C.B., Knochel P. 2,3-Functionalization of furans, benzofurans and thiophenes via magnesiation and sulfoxide-magnesium exchange. Chem. Commun. 2009:3536–3538. doi: 10.1039/b907330b. [DOI] [PubMed] [Google Scholar]
  • 9.Bach T., Krüger L. The preparation of 2,3,5-tri- and 2,3-disubstituted furans by regioselective palladium(0)-catalyzed coupling reactions: Application to the syntheses of rosefuran and the F5 furan fatty acid. Eur. J. Org. Chem. 1999:2045–2057. doi: 10.1002/(SICI)1099-0690(199909)1999:9<2045::AID-EJOC2045>3.0.CO;2-6. [DOI] [Google Scholar]
  • 10.Moran W.J., Rodríguez A. Metal-catalyzed furan synthesis. A review. Org. Prep. Proced. Int. 2012;44:103–130. doi: 10.1080/00304948.2012.657558. [DOI] [Google Scholar]
  • 11.Palmieri A., Gabrielli S., Ballini R. Efficient two-step sequence for the synthesis of 2,5-disubstituted furanderivatives from functionalized nitroalkanes: Successive AmberlystA21- and Amberlyst 15-catalyzed processes. Chem. Commun. 2010;46:6165–6167. doi: 10.1039/c0cc01097a. [DOI] [PubMed] [Google Scholar]
  • 12.Minkler S.R.K., Isley N.A., Lippincott D.J., Krause N., Lipshutz B.H. Leveraging the micellar effect: Gold-catalyzed dehydrative cyclizations in water at room temperature. Org. Lett. 2014;16:724–726. doi: 10.1021/ol403402h. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Palisse A., Kirsch S.F. Synthesis of furans through silver-catalyzed propargyl–Claisen rearrangement followed by cyclocondensation. Eur. J. Org. Chem. 2014;32:7095–7098. doi: 10.1002/ejoc.201402983. [DOI] [Google Scholar]
  • 14.Sampaolesi S., Gabrielli S., Ballini R., Palmieri A. Two-Step synthesis of polysubstituted 6-nitroindoles under flow chemical and microwave conditions. Adv. Synth. Catal. 2017;359:3407–3413. doi: 10.1002/adsc.201700790. [DOI] [Google Scholar]
  • 15.Palmieri A., Gabrielli S., Parlapiano M., Ballini R. One-pot synthesis of alkyl pyrrole-2-carboxylates starting from β-nitroacrylates and primary amines. RSC Adv. 2015;5:4210–4213. doi: 10.1039/C4RA13094D. [DOI] [Google Scholar]
  • 16.Chiurchiù E., Patehebieke Y., Gabrielli S., Ballini R., Palmieri A. β-Nitroacrylates as starting materials of thiophene-2-carboxylates under continuous flow conditions. Adv. Synth. Catal. 2019;361:2042–2047. doi: 10.1002/adsc.201801660. [DOI] [Google Scholar]
  • 17.Gabrielli S., Chiurchiù E., Palmieri A. β-Nitroacrylates: A versatile and growing class of functionalized nitroalkenes. Adv. Synth. Catal. 2019;361:630–653. doi: 10.1002/adsc.201800709. [DOI] [Google Scholar]
  • 18.Ballini R., Gabrielli S., Palmieri A. β-Nitroacrylates as precursors of tetrasubstituted furans in a one-pot process and under acidic solvent-free conditions. Synlett. 2010:2468–2470. doi: 10.1002/chin.201106121. [DOI] [Google Scholar]
  • 19.Ballini R., Palmieri A. Formation of carbon-carbon double bonds: Recent developments via nitrous acid elimination (NAE) from aliphatic nitro compounds. Adv. Synth. Catal. 2019;361:5070–5097. doi: 10.1002/adsc.201900563. [DOI] [Google Scholar]
  • 20.Ballini R., Gabrielli S., Palmieri A., Petrini M. A two-step synthesis of unsymmetrical 1,4-disubstituted carbazoles from sulfonylindoles under heterogeneous catalysis. Adv. Synth. Catal. 2010;352:2459–2462. doi: 10.1002/adsc.201000394. [DOI] [Google Scholar]
  • 21.Kadota J., Chatani N., Murai S. A platinum complex-catalyzed reaction of 3-chloro-1,3-diene monoepoxides with carbon nucleophiles involving nucleophilic substitution at the central carbon atom of the π-allyl ligand in the intermediate complex. Dependency of regioselectivity upon the added Lewis acids. Tetrahedron. 2000;56:2231–2237. doi: 10.1016/S0040-4020(99)01106-0. [DOI] [Google Scholar]

Articles from Molecules are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES